a16z Capital Management, L.L.C.
Top Portfolio Positions
16 positions ·
$1,290,612,461 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| NAVN |
Navan, Inc.
Technology
|
28,218,676 | $373,615,270 | 28.95% | |
| FIG |
Figma, Inc.
Technology
|
16,011,378 | $338,480,530 | 26.23% | |
| META |
Meta Platforms, Inc.
Communication Services
|
212,531 | $121,595,361 | 9.42% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
921,099 | $89,576,877 | 6.94% | |
| NAUT |
Nautilus Biotechnology, Inc.
Healthcare
|
17,653,917 | $68,497,197 | 5.31% | |
| XYZ |
Block, Inc.
Technology
|
1,016,697 | $61,184,825 | 4.74% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
3,233,170 | $56,548,143 | 4.38% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
1,702,225 | $50,811,416 | 3.94% | |
| ERAS |
Erasca, Inc.
Healthcare
|
2,862,500 | $46,315,250 | 3.59% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
1,236,157 | $32,016,466 | 2.48% |
Portfolio Trend
Holdings in DNA
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $665,521 | 108,568 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $902,200 | 108,568 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,582,921 | 108,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,221,390 | 108,568 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $618,837 | 108,568 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,066,137 | 108,568 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $884,829 | 108,568 | Shares | Sole | 2024-11-13 | |
| No 13F history on record for this holder in this stock. | ||||||